1. Introduction {#sec1}
===============

Brucellosis is a zoonotic infection transmitted to humans from fluids of infected animals or through consumption of unpasteurised dairy products [@bib1]. It is caused by *Brucella* spp., intracellular Gram-negative coccobacilli. Four species cause most cases of human disease, each with a different animal host reservoir: *Brucella melitensis* (goats, camels) is most common, followed by *Brucella abortus* (cattle), *Brucella suis* (pigs) and *Brucella canis* (dogs). Infections with new species such a *Brucella pinnepedialis* and *Brucella ceti* (marine animals) are occasionally recognized [@bib2]. It can cause an acute febrile illness after a usual incubation period of 1--4 weeks, ranging up to 6 months, or chronic infection, which can be without focus or can affect any organ system. Osteoarticular involvement is the most common focal presentation. Diagnosis is usually based on serology, augmented when possible by culture of *Brucella* organisms from blood, synovial fluid, or bone. Promising molecular methods are in development. Treatment is usually with combination therapy of doxycycline, rifampicin ± an aminoglycoside for 6--12 weeks [@bib1]. Prosthetic joint infections (PJI) caused by *Brucella* spp. are uncommonly reported in the literature. We describe a PJI caused by *B. melitensis* in a traveller returning to the UK from Thailand, the first detailed report of brucellosis in a traveller returning from this area; we also present a review of the 24 reported cases of Brucella-related PJI in the literature.

2. Materials and methods {#sec2}
========================

2.1. Case report {#sec2.1}
----------------

A 51-year old UK resident attended our clinic on 5 May 2015 with a 21-day history of daily rigors, profuse sweating attacks and high fever. He had returned from Thailand three months earlier. He also had pain and swelling in his left knee, in which he had an uncomplicated total knee replacement 5 years previously for early onset osteoarthritis following trauma. The only abnormalities on examination were fever of 38.3 °C and a small effusion in the symptomatic knee. Blood cultures yielded Gram-negative coccobacilli after 3 days (BioMerieux Bact/ALERT blood culture system), identified as *B. melitensis* by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (Bruker microflex LT), but not before two laboratory scientists had been exposed to open bacterial culture plates. The organism was confirmed as *B. melitensis* biotype 3 in the Veterinary Investigation Centre in Weybridge. Standard agglutination tests for brucellosis were suggestive of chronic infection, with IgG titres of \>1:2560 and IgM 1:80.

Aspiration of the knee was carried out by the orthopaedic team, equipped with personal protective equipment \[PPE\] consisting of gown, gloves, apron, visor and filtering face piece-3 \[FFP3\] respirator. Cloudy fluid was aspirated; this contained over 6000 lymphocytes/mm^3^ and cultured *B. melitensis* after 7 days. The patient commenced doxycycline and rifampicin 600 mg daily for 6 months, together with parenteral gentamicin 5 mg/kg/day for the first 14 days, with resolution of his symptoms and preservation of his implant without revision surgery. Twelve months later he has fully recovered with no signs of loosening of the joint prosthesis on plain x-rays. The exposed laboratory personnel were given doxycycline 100 mg twice daily for 21 days as postexposure prophylaxis according to UK guidelines [@bib3].

The patient made frequent visits to Thailand where he had most recently stayed with a friend on his farm in Nakom Pathom province from 11 December 2014 to 8 January 2015. During that time, he helped deliver several parturient goats and handled newly born kids and other products of conception with his bare hands. He had not consumed unpasteurised dairy products and had no contact with cattle or buffaloes. Two farm workers had contemporaneous fevers, only recognised to be due to brucellosis and treated appropriately after our patient was diagnosed.

2.2. Literature review {#sec2.2}
----------------------

PubMed and Scopus databases were searched using the search string (((((((*prosth\**) *OR replacement*)) *OR arthroplasty*)) *AND* (((*knee*) *OR hip*) *OR joint*))) *AND brucell\**. Studies were reviewed and data extracted by one author (JL), with no restriction on date or language. Prosthetic joint brucellosis was defined as either a) *Brucella* spp. recovered from prosthetic joint synovial fluid culture OR b) signs and symptoms consistent with PJI AND *Brucella* spp. recovered from blood OR positive serology (standard agglutination test \[SAT\] titre \> 1:160 OR fourfold rise in titre between acute and convalescent samples).

3. Results and discussion {#sec3}
=========================

The search returned 48 results in Scopus and 26 in PubMed. After removal of duplicates, 47 remained. 18 reports contained data on 23 patients with 26 *Brucella*-related prosthetic joint infections; only 3 were in returning travellers [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21]. [Table 1](#tbl1){ref-type="table"} summarises all 24 patients including: gender, country of exposure, type of implant and time to symptom onset. In all cases *Brucella* spp. were recovered from blood, synovial fluid or operative tissue sample. No diagnoses were made using serology alone.

It is possible to draw several conclusions from these cases; *Brucella-*related PJI is a late complication of joint arthroplasty, with a median onset of 36 months after the procedure. The diagnosis can be difficult to make: only 30% (3/10) of reported blood cultures and 75% (9/12) of reported joint aspiration samples cultured *Brucella* organisms. Culture of intra-operative tissue samples probably provides the best yield and confirmed the diagnosis in 15/24 cases; in these 15 cases joint aspiration was either not carried out (12/15) or was culture-negative (3/15). In the absence of radiological evidence of implant loosening, medical management with antibiotics alone appears to be effective in the first instance; of 24 patients with 27 infected prosthetic joints, 7 patients (with 9 infected prosthetic joints) had radiologically well-seated implants with no abscess or draining sinus. These patients underwent antibiotic treatment alone for between 6 and 52 weeks, with cure in 6/7 patients (8/9 joints) and failure of medical therapy necessitating surgery in only one patient (one joint). One patient with an infected joint that was radiologically well seated had a draining sinus, but was successfully treated with debridement and adjuvant antibiotics without explant of the prosthesis. However, caution must be exercised in drawing firm conclusions on optimal treatment from these data, given the small numbers and the likelihood of selection bias inherent in case reports.

Sixteen patients (with 17 infected joints) had features of loosening on imaging; these all underwent either 1- or 2-stage revision of their prosthesis alongside antibiotic therapy, all with favourable outcome. One patient was lost to follow up. Follow up was for a median of 24 months.

These cases also provide some guidance on appropriate infection control measures when considering a diagnosis of *Brucella-*related PJI. Infection of laboratory staff by exposure to *Brucella* spp. is well recognised. Procedures that generate aerosolized bacteria provide the highest risk of exposure [@bib22]. Synovial fluid from *Brucella*-infected joints is likely to have a lower bacillary load than culture bottles or plates and therefore exposure to synovial fluid during joint aspiration or joint revision surgery probably represents a lower risk exposure. Nevertheless, a case of transmission during joint aspiration has been described, to a radiology technician who assisted with injecting synovial fluid from a *Brucella*-infected joint from a syringe into a sample container [@bib20]. Neither UK [@bib3] nor US guidelines [@bib23] provide recommendations for risk assessment of potential *Brucella* exposure outside the laboratory, or recommendations for PPE while performing joint aspiration or surgery. We recommend that healthcare workers undertaking aspiration of or surgery on joints in which *Brucella* infection is suspected or confirmed are outfitted with PPE including gown, visor and fit-tested FFP3 respirator or equivalent.

Brucellosis is not a diagnosis that would usually be considered in a traveller returning from Thailand [@bib24]. Two cases acquired in Thailand have been mentioned in passing in reviews of children [@bib25] and adult [@bib26] travellers returning to North America and Europe respectively. Foci in China, Mongolia and Central Eurasia are well recognised but the range of other countries newly affected by brucellosis continues to expand [@bib2], [@bib27], [@bib28], [@bib29], [@bib30]. Human infections are under-reported compared to the patchy knowledge of its increasing incidence in livestock in South Asia [@bib31]. A boy acquired brucellosis from raw goat\'s milk in Penang, Malaysia in 2010 and a German visitor acquired brucellosis in Myanmar from drinking lassi [@bib32]. An outbreak of caprine and human brucellosis in Ratchaburi Province in Thailand was investigated in 2003 [@bib33] and there have been sporadic case reports and more recent reviews of emerging brucellosis endemicity in Thailand over the past decade [@bib34], [@bib35], [@bib36]. As demonstrated by our patient, the highest risk to humans in Thailand is exposure to parturient goats (*B. melitensis*) but there is a separate risk of *B. abortus* transmission from buffaloes. Diagnosis of illness in travellers can highlight the presence of locally unrecognised infections, as shown by this patient and his contacts.

4. Conclusion {#sec4}
=============

In conclusion, we report the first detailed case report of brucellosis in a traveller returning from Thailand. Clinicians should consider brucellosis as well as the more commonly encountered causes of fever in returnees from this area. Brucellosis should be included in the list of possible causes of an infected prosthetic joint in patients who have an appropriate epidemiological risk and PPE, including fit-tested masks, should be used by operators undertaking joint aspiration or surgery in such cases. Though the small number of cases identified in this review warrants caution about drawing any firm conclusions regarding optimal treatment, in the absence of implant loosening, treatment with antibiotics may be appropriate in the first instance. There are no specific strategies for avoidance of *Brucella* spp. PJI beyond those needed by all travellers to prevent brucellosis. These include the avoidance of unpasteurised dairy products (including lassi and buffalo milk or cheese) and animal contact (particularly in farms or abattoirs) in endemic areas. Travellers (with or without prosthetic joints) should be made aware of these risks as part of their standard pre-travel assessment.
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Preliminary data about this patient were published on-line in May 2015 \[32\], and reported through the GeoSentinel network (of which LSTM is a contributing centre). We thank the patient for consenting to his details being published.

###### 

Summary of 24 patients with *Brucella* spp. prosthetic joint infection.

Table 1

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                         Age   Sex   Country of exposure   Traveller   Occupation            Prosthetic implant             Time since implantation (months)   Brucella SAT titre   Radiographic changes   Blood cultures positive   Joint aspirate culture positive   Species           Antibiotics used                          Antibiotic course length (weeks)                                                Surgical management                                                                                           Follow up (months)   Outcome
  --------------------------------- ----- ----- --------------------- ----------- --------------------- ------------------------------ ---------------------------------- -------------------- ---------------------- ------------------------- --------------------------------- ----------------- ----------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------- -------------------- --------------------------------------------------------
  Jones et al., 1983 [@bib4]        54    M     USA                   No          Dairy farmer          R THR                          6                                  640                  No loosening           No                        No                                *B. abortus*      Tetracycline 500 mg QID\                  6 -- failed therapy; followed by 52 weeks; Streptomycin first 6 only            One stage revision once medical treatment failed                                                              24                   Asymptomatic
                                                                                                                                                                                                                                                                                                    Streptomycin 500 mg BID                                                                                                                                                                                                                                      

  Agarwal et al., 1991 [@bib5]      24    F     Saudi Arabia          No          NR                    Bilateral TKR                  2                                  2560                 No loosening           No                        Yes                               *B. melitensis*   Rifampicin 300 mg BID\                    76                                                                              None                                                                                                          19                   Pain free, flexion 0--90
                                                                                                                                                                                                                                                                                                    Co-trimoxazole 980 mg BID                                                                                                                                                                                                                                    

  Orti et al., 1997 [@bib6]         60    M     Spain                 No          "Works with goats"    R TKR                          14                                 160                  No oosening            No                        Yes                               *B. melitensis*   Doxycycline 100 mg BID\                   6\                                                                              None                                                                                                          8                    Symptom free
                                                                                                                                                                                                                                                                                                    Rifampicin 900 mg QD\                     Streptomycin first 3 only                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                    Streptomycin 1 g QD                                                                                                                                                                                                                                          

  Navarro et al., 1997 [@bib7]      54    M     Spain                 No          Shepherd              L internal fixation of femur   324                                160                  Loosening              No                        NR                                *B. melitensis*   Doxycycline 100 mg BID\                   34\                                                                             Removal of implant and debridement                                                                            18                   Asymptomatic
                                                                                                                                                                                                                                                                                                    Gentamicin 240 mg QD                      Gentamicin first 1 only                                                                                                                                                                                            

  Malizos et al., 1997 [@bib8]      74    M     Greece                No          Shepherd              Bilateral TKR                  5                                  160                  No loosening           Yes                       Yes                               *B. melitensis*   Doxycycline Streptomycin Co-trimoxazole   20\                                                                             None                                                                                                          24                   Asymptomatic
                                                                                                                                                                                                                                                                                                                                              Streptomycin first 3 only                                                                                                                                                                                          

  Ortega et al., 2002 [@bib9]       63          Spain                 No          Cattle owner          R THR                          60                                 NR                   Loosening              No                        NR                                *B. melitensis*   Doxycycline 100 mg BID\                   12\                                                                             Two-stage revision                                                                                            6                    "Satisfactory"
                                                                                                                                                                                                                                                                                                    Rifampicin 900 mg QD\                     Streptomycin first 3 only                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                    Streptomycin 1 g QD                                                                                                                                                                                                                                          

  Weil et al., 2003 [@bib10]        38    M     Israel                No          Artist                L THR                          48                                 1600                 Loosening              NR                        No                                *B. melitensis*   Doxycycline 200 mg QD\                    12\                                                                             Two-stage revision                                                                                            12                   Asymptomatic
                                                                                                                                                                                                                                                                                                    Rifampicin 600 mg QD                      6 prior to surgery, 6 after                                                                                                                                                                                        

  Weil et al., 2003 [@bib10]        61    M     Israel                No          Retired               R TKR                          60                                 1600                 Loosening              NR                        No                                *B. melitensis*   Doxycycline 200 mg QD\                    12\                                                                             Two-stage revision                                                                                            12                   Free of joint pain
                                                                                                                                                                                                                                                                                                    Rifampicin 600 mg QD                      6 prior to surgery, 6 after                                                                                                                                                                                        

  Weil et al., 2003 [@bib10]        67    M     Israel                No          Retired               L TKR                          168                                1600                 Loosening              NR                        Yes                               *B. melitensis*   Doxycycline 200 mg QD\                    12\                                                                             Two-stage revision                                                                                            12                   Free of joint pain
                                                                                                                                                                                                                                                                                                    Rifampicin 600 mg QD                      6 prior to surgery, 6 after                                                                                                                                                                                        

  Kasim et al., 2004 [@bib11]       47    F     Lebanon               No          NR                    L THR                          168                                640                  Loosening              NR                        NR                                *Brucella* spp.   Doxycycline 100 mg BID\                   20                                                                              One-stage revision                                                                                            48                   Symptom free, negative *Brucella* titres
                                                                                                                                                                                                                                                                                                    Rifampicin 600 mg QD                                                                                                                                                                                                                                         

  Cairo et al., 2006 [@bib12]       50    M     Spain                 No          NR                    L THR                          0                                  320                  No loosening           Yes                       NR                                *B. melitensis*   Doxycycline 100 mg BID\                   104 Streptomycin first 2 only                                                   None                                                                                                          60                   Well, negative *Brucella* titres
                                                                                                                                                                                                                                                                                                    Streptomycin 1 g QD                                                                                                                                                                                                                                          

  Cairo et al., 2006 [@bib12]       71    M     Spain                 No          Farmer                R THR                          36                                 NR                   Loosening              No                        NR                                *B. melitensis*   Doxycycline 100 mg BID\                   24\                                                                             Initially one stage revision (infection not suspected); later revision THR after failure of medical therapy   36                   Well, negative *Brucella* titres
                                                                                                                                                                                                                                                                                                    Rifampicin 600 mg QD\                     Streptomycin first week only                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                    Streptomycin 750 mg QD                                                                                                                                                                                                                                       

  Cairo et al., 2006 [@bib12]       74    F     Spain                 No          NR                    L tibial plate                 180                                80                   NR                     NR                        NR                                *B. melitensis*   Doxycycline 100 mg BID\                   32\                                                                             Initially bone graft and medical therapy -- failed -- then two stage revision                                 36                   Satisfactory range of movement 0--100° knee
                                                                                                                                                                                                                                                                                                    Rifampicin 300 mg TID\                    Doxycycline/streptomycin first week Doxycycline/rifampicin for remainder                                                                                                                                           
                                                                                                                                                                                                                                                                                                    Streptomycin 1 g QD                                                                                                                                                                                                                                          

  Ruiz-Iban et al., 2006 [@bib13]   66    F     Spain                 No          Housewife             THR                            36                                 NR                   Loosening              NR                        Yes                               *B. abortus*      Doxycycline 200 mg QD\                    6                                                                               Two-stage revision                                                                                            66                   Asymptomatic
                                                                                                                                                                                                                                                                                                    Rifampicin 900 mg QD                                                                                                                                                                                                                                         

  Ruiz-Iban et al., 2006 [@bib13]   71    M     Spain                 No          Agricultural worker   THR                            28                                 640                  No loosening           NR                        No                                *B. melitensis*   Doxycycline 200 mg QD\                    24 Streptomycin first 6 only                                                    Debridement                                                                                                   60                   Asymptomatic
                                                                                                                                                                                                                                                                                                    Rifampicin 900 mg QD\                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                    Streptomycin 200 mg QD                                                                                                                                                                                                                                       

  Marbach et al., 2007 [@bib14]     67    NR    Sicily                Yes         NR                    Bilateral TKR                  48                                 NR                   Loosening              NR                        NR                                *Brucella* spp.   Doxycycline 100 mg BID\                   12                                                                              Two-stage revision                                                                                            15                   Good range of movement
                                                                                                                                                                                                                                                                                                    Rifampicin 450 mg BID                                                                                                                                                                                                                                        

  Tena et al., 2007 [@bib15]        56    M     Spain                 No          Farmer                L THR                          60                                 80                   Loosening              No                        Yes                               *B. melitensis*   Doxycycline 100 mg BID\                   8 Doxycycline/streptomycin first 2 weeks Doxycycline/rifampicin for remainder   Two-stage revision                                                                                            60                   Asymptomatic, good joint function
                                                                                                                                                                                                                                                                                                    Rifampicin 900 mg QD\                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                    Streptomycin 1 g QD                                                                                                                                                                                                                                          

  Tassinari et al., 2008 [@bib16]   68    M     Italy                 No          NR                    R TKR                          24                                 800                  No loosening           NR                        Yes                               *B. melitensis*   Doxycycline 100 mg BID\                   8                                                                               None                                                                                                          12                   Pain disappeared, no radiographic changes
                                                                                                                                                                                                                                                                                                    Rifampicin 250 mg QD                                                                                                                                                                                                                                         

  Dauty et al., 2009 [@bib17]       65    F     Portugal              Yes         NR                    Bilateral TKR                  NR                                 NR                   Loosening              NR                        NR                                *B. melitensis*   Doxycycline 200 mg QD\                    12                                                                              Two-stage revision                                                                                            120                  Pain free, walking distance \> 1 km
                                                                                                                                                                                                                                                                                                    Rifampicin 900 mg QD                                                                                                                                                                                                                                         

  Erdogan et al., 2010 [@bib18]     63    F     Turkey                No          NR                    R TKR                          24                                 160                  NR                     NR                        NR                                *B. melitensis*   Doxycycline 200 mg QD\                    20\                                                                             One-stage revision                                                                                            36                   Free of joint pain, negative serology
                                                                                                                                                                                                                                                                                                    Rifampicin 600 mg QD                      Initially 6 weeks, followed by revision TKR, then 16 weeks                                                                                                                                                         

  Nichols et al., 2014 [@bib19]     67    F     Mexico                No          NR                    THR                            24                                 NR                   Loosening              NR                        NR                                *B. abortus*      Doxycycline Rifampicin                    12                                                                              Two-stage revision                                                                                                                 No evidence of infection recurrence

  Lowe et al., 2015 [@bib20]        NR    NR    India                 Yes         NR                    THR                            NR                                 NR                   NR                     NR                        Yes                               *B. melitensis*   None -- lost to follow up                 N/a                                                                             None                                                                                                          0                    Unknown

  Carothers et al., 2015 [@bib21]   67    F     USA or Mexico         No          NR                    R THR                          24                                 NR                   Loosening              NR                        NR                                *B. abortus*      Doxycycline 100 mg BID\                   20                                                                              Two-stage revision                                                                                            24                   Well, no evidence of infection
                                                                                                                                                                                                                                                                                                    Rifampicin 300 mg BID                                                                                                                                                                                                                                        

  Present case                      51    M     Thailand              Yes         Company director      L TKR                          60                                 \>2560               No loosening           Yes                       Yes                               *B. melitensis*   Doxycycline 200 mg QD\                    24\                                                                             None                                                                                                          12                   Well, pain free, fully mobile, no radiographic changes
                                                                                                                                                                                                                                                                                                    Rifampicin 600 mg QD\                     Gentamicin first 2 weeks only                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                    Gentamicin 400 mg QD                                                                                                                                                                                                                                         
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

M = male, F = female, L = left, R = right, NR = not reported, SAT = Standard agglutination test, QD = quaque die \[once daily\], BID = bis in die \[twice daily\], TID = ter in die \[thrice daily\], QID = quater in die \[four times daily\], THR = total hip replacement, TKR = total knee replacement. Where dose and/or dosing interval are given in original report, they are reproduced here.
